Reg A Rundown | New Cannabis Deal & Updates from Miso Robotics, 20/20 & More from SeedInvest

Click to rate this post!
[Total: 0 Your Rating: 0]

We are excited to introduce our latest Reg A+ campaign now accepting reservations – Good Earth Organics is producing certified organic potting soils & nutrients for toxin-free cannabis and hemp plants. Read on for more updates from 20/20 GeneSystems, Cytonics, GROUNDFLOOR, Graze, Caliber, and Miso Robotics.

Now Accepting Reservations

Good Earth Organics | Certified organic potting soils & nutrients for toxin-free cannabis and hemp plants
Good Earth Organics (GEO) produces and markets premium organic potting soils and nutrients, specially formulated to maximize cannabis and hemp flower growth.
Notable deal highlights include:
• Revenue grew 43% in 2019 to over $3mm
• 60% revenue growth in 1H 2020 (unaudited) compared to 1H 2019 (audited) with improved COGS resulting in better gross profit (1H 2020 numbers reflected are subject to change pending audit, in addition expenses have not yet been prepared)
• Organic certifications from both OMRI & Clean Green (independent certifiers that test and approve soils for organic growing)
• Management team and owners are graduates of Stanford, Harvard, Harvard Business School, and Northwestern’s Kellogg School of Management and have decades of experience in private equity and building companies at places such as Bear Stearns, Etsy, and Indiegogo
By confirming a reservation, you have the opportunity to purchase shares ahead of the company’s public launch as it awaits SEC qualification. A reservation is non-binding and you may cancel at any time.

Business Updates

20/20 to launch OneTest cancer pilot with Ping An
20/20 GeneSystems recently entered into a non-binding Memorandum of Understanding (MOU) with the Ping An Medical Group which provides that 20/20’s OneTest for cancer would be utilized on a trial basis in one of Ping An’s health check centers. If the pilot is successful, the parties will negotiate a full commercial arrangement to launch OneTest in China nationwide.

Cytonics’ preclinical results indicate signs of safety & efficacy
Cytonics is excited to announce its recent preclinical research results: “The purpose of this pilot preclinical study was to examine whether CYT-108 is a feasible drug candidate for treating osteoarthritis,” comments Cytonics President Joey Bose. “The results demonstrated CYT-108, our lead drug candidate, was generally tolerated when injected. Moreover, we also observed slight cartilage-protective effects when CYT-108 was administered into damaged joints.”

Graze develops new safety feature – identifying humans
Recently, Graze further developed its computer vision to recognize humans so that the machine can cease activity as necessary, much like a landscaper would do if a pedestrian walked by. Using artificial intelligence, the cameras on Graze’s autonomous mower would be capable of identifying a human in its path or even just a body part that comes into view.

Caliber secures deal with largest homebuilder in the U.S.
Caliber recently signed a contract with D.R. Horton, the largest homebuilder by volume in the country. Per the contract, Horton purchased 80 residential lots in Caliber’s “The Ridge,” a mixed-use development in Johnstown, CO. As new partners in this venture, Caliber will fully develop said lots and D.R. Horton will build and sell the homes.

GROUNDFLOOR named “Deal to Watch” by KingsCrowd
GROUNDFLOOR, a wealthtech platform offering real estate investments to everyone, was recently featured in KingsCrowd as a “Deal to Watch.” This distinction is reserved for deals in the top 10-20% of KingsCrowd’s investment research funnel.

Miso Robotics receives press from news publications around the globe
Miso Robotics and White Castle recently entered into an agreement to develop, pilot, and undertake a beta rollout of Miso Robotics’ Flippy robot for White Castle’s North American restaurants. The partnership has already picked up press from TechCrunch, Business Insider, Forbes, Yahoo! News, Fox, CNN, The Tonight Show with Jimmy Fallon, NPR, and more. “The AI not only ensures better consistency, but also accuracy by removing the possibility of human error.”


Join Our Newsletter



By Registering, you agree that you've read and accepted our disclaimer, you're at least 18 years old, you consent to the terms presented on the disclaimer, and to receive notifications from us.